Drug Patent List
First Filer Exclusivity TimelineNew
Newsletter
Weekly Digest

Pharsight

Eurofarma Drug Patent Portfolio

Eurofarma's Family Patents


Family Patents





Clinical Trials

Recent Clinical Trials by Eurofarma:

Title Lead Sponsor Collaborators Status Phases
Clinical Trials
A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment Eurofarma Laboratorios S.A. NA COMPLETED
(Sep 1, 2026)
PHASE3
Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of Migraine Eurofarma Laboratorios S.A. NA COMPLETED
(Sep 1, 2026)
PHASE3
Treatment of Androgenetic Alopecia in Men for 24 Weeks Eurofarma Laboratorios S.A. NA COMPLETED
(Sep 1, 2026)
PHASE3
Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children Eurofarma Laboratorios S.A. NA COMPLETED
(Sep 1, 2026)
PHASE3
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR) Eurofarma Laboratorios S.A. NA NOT YET RECRUITING
(Sep 1, 2026)
PHASE3
Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension Eurofarma Laboratorios S.A. NA WITHDRAWN
(Sep 1, 2026)
PHASE3
Study of Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg in Patients With Asthma (FORASMA) Eurofarma Laboratorios S.A. NA WITHDRAWN
(Sep 1, 2026)
PHASE3
Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA) Eurofarma Laboratorios S.A. NA NOT YET RECRUITING
(Jul 1, 2026)
PHASE3
Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. Eurofarma Laboratorios S.A. NA NOT YET RECRUITING
(Apr 1, 2026)
PHASE3


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List